Perigon Wealth Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $797K | Buy |
2,060
+918
| +80% | +$340K | 0.01% | 680 |
|
|
2026
Q1 | $334K | Sell |
1,142
-229
| -17% | -$75.3K | 0.01% | 975 |
|
|
2025
Q4 | $481K | Buy |
1,371
+29
| +2% | +$9.8K | 0.01% | 818 |
|
|
2025
Q3 | $434K | Sell |
1,342
-151
| -10% | -$47K | 0.01% | 796 |
|
|
2025
Q2 | $581K | Sell |
1,493
-2,570
| -63% | -$1.03M | 0.01% | 627 |
|
|
2025
Q1 | $1.77M | Sell |
4,063
-32
| -0.8% | -$12.8K | 0.05% | 330 |
|
|
2024
Q4 | $1.58M | Buy |
4,095
+1,866
| +84% | +$781K | 0.04% | 345 |
|
|
2024
Q3 | $1.16M | Sell |
2,229
-45
| -2% | -$24K | 0.03% | 398 |
|
|
2024
Q2 | $1.23M | Sell |
2,274
-95
| -4% | -$50.2K | 0.04% | 324 |
|
|
2024
Q1 | $1.23M | Buy |
2,369
+351
| +17% | +$175K | 0.04% | 327 |
|
|
2023
Q4 | $952K | Buy |
2,018
+157
| +8% | +$72.6K | 0.03% | 349 |
|
|
2023
Q3 | $810K | Sell |
1,861
-274
| -13% | -$124K | 0.03% | 343 |
|
|
2023
Q2 | $948K | Buy |
2,135
+36
| +2% | +$16.6K | 0.04% | 328 |
|
|
2023
Q1 | $965K | Sell |
2,099
-182
| -8% | -$86.6K | 0.05% | 276 |
|
|
2022
Q4 | $1.17M | Buy |
2,281
+444
| +24% | +$225K | 0.07% | 242 |
|
|
2022
Q3 | $834K | Buy |
1,837
+131
| +8% | +$62.7K | 0.07% | 227 |
|
|
2022
Q2 | $823K | Buy |
1,706
+99
| +6% | +$49K | 0.07% | 237 |
|
|
2022
Q1 | $790K | Buy |
1,607
+65
| +4% | +$29.7K | 0.06% | 272 |
|
|
2021
Q4 | $715K | Buy |
1,542
+72
| +5% | +$30.3K | 0.05% | 270 |
|
|
2021
Q3 | $548K | Sell |
1,470
-28
| -2% | -$10.6K | 0.05% | 290 |
|
|
2021
Q2 | $572K | Buy |
1,498
+124
| +9% | +$47.4K | 0.05% | 281 |
|
|
2021
Q1 | $493K | Buy |
1,374
+616
| +81% | +$198K | 0.05% | 294 |
|
|
2020
Q4 | $243K | Buy |
+758
| New | +$233K | 0.03% | 364 |
|
|
2018
Q2 | – | Sell |
-458
| Closed | -$101K | – | 344 |
|
|
2018
Q1 | $101K | Hold |
458
| – | – | 0.04% | 231 |
|
|
2017
Q4 | $103K | Buy |
458
+65
| +17% | +$13.8K | 0.04% | 196 |
|
|
2017
Q3 | $75K | Hold |
393
| – | – | 0.02% | 294 |
|
|
2017
Q2 | $74K | Hold |
393
| – | – | 0.02% | 333 |
|
|
2017
Q1 | $65K | Hold |
393
| – | – | 0.01% | 363 |
|
|
2016
Q4 | $65K | Hold |
393
| – | – | 0.01% | 328 |
|
|
2016
Q3 | $49K | Buy |
393
+55
| +16% | +$7.1K | 0.01% | 314 |
|
|
2016
Q2 | $44K | Buy |
+338
| New | +$46.2K | 0.01% | 290 |
|
Other funds holding ELV
Perigon Wealth Management's ELV Position: Q2 2026 in Review
Perigon Wealth Management increased its Elevance Health (ELV) stake by 80% in Q2 2026, buying an estimated $340K and bringing the position to 2,060 shares worth $797K. The position accounts for 0.01% of the portfolio, ranked #680.
Perigon Wealth Management first reported a position in ELV in Q2 2016 and has held it in 31 quarters since. The position peaked at $1.77M in Q1 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Perigon Wealth Management held 2,060 shares of Elevance Health worth $797K as of Q2 2026.
- Perigon Wealth Management bought 918 Elevance Health shares in Q2 2026, an estimated $340K.
- Elevance Health made up 0.01% of Perigon Wealth Management's portfolio in Q2 2026, its #680 holding.
- Perigon Wealth Management first reported a position in Elevance Health in Q2 2016 and has held it in 31 quarters since.
- Perigon Wealth Management's Elevance Health position peaked at $1.77M in Q1 2025.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Perigon Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.